NGO nonpaper on aid for fleet renewal

Full document (PDF - 5 pages):

Français / English

Funding fleet renewal will not address EU overcapacity and overfishing

Thirty years of the Common Fisheries Policy, CFP, has resulted in the serious depletion of fish populations, the degradation of ecosystems, and damage to species and habitats. Thirty-nine per cent of assessed stocks in the Atlantic and 88 per cent in the Mediterranean are overfished1. By continuing to overfish, more than €3 billion every year is being wasted which could support more than 100,000 jobs2. Overcapacity is one of the main drivers of overfishing and subsidies have been used to increase the EU’s fleet capacity by providing aid for the construction of new vessels. So much so, that the EU’s fishing fleet is estimated to be two to three times larger than sustainable fisheries would allow. Such direct subsidies have acted as an economic incentive to overfish; reducing them is critical to ending overfishing, rebuilding fish stocks and securing a viable future for the sector.

America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.